News
Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response. The Independent Data Monitoring Commi ...
From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...
Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
20h
TipRanks on MSNUnited Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary FibrosisUnited Therapeutics Corp. (($UTHR)) announced an update on their ongoing clinical study. Study Overview: United Therapeutics Corp. is conducting a ...
With limited treatment options and potential for admission to the intensive care unit, researchers of a new paper highlighted ...
In the U.S., new cases of pulmonary fibrosis have been increasing in recent years and patients hospitalized for severe COVID-19 may be at particular risk, according to the researchers.
With the acquisition, Merck gets access to Verona Pharma's chronic obstructive pulmonary disease medication Ohtuvayre. The Food and Drug Administration approved Ohtuvayre in June 2024 for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results